[en] ABSTRACT: BACKGROUND: The prevalence of the metabolic syndrome (MS) has been determined in many countries worldwide but never in Luxembourg. This research aimed to 1) establish the gender- and age-specific prevalence of MS and its components in the general adult population of Luxembourg, according to the most recent Joint Interim Statement (JIS) definition, by using both the high and low cut-off points to define abdominal obesity, and 2) compare and assess the degree of agreement with the Revised National Cholesterol Education Programme-Adult Treatment Panel III (R-ATPIII) and the International Diabetes Federation (IDF) definitions. METHODS: A representative stratified random sample of 1349 European subjects, aged 18-69 years, participated to ORISCAV-LUX survey. Logistic regression and odds ratios (OR) were used to study MS prevalence with respect to gender and age. The Framingham risk score (FRS) to predict the 10-year coronary heart disease (CHD) risk was calculated to compare the proportion of MS cases below or above 20%, according to both high and low waist circumference (WC) thresholds. Cohen's kappa coefficient (kappa) was utilized to measure the degree of agreement between MS definitions. RESULTS: The prevalence of the MS defined by the JIS was 28.0% and 24.7% when using the low (94/80) and the high (102/88) WC cut-off points, respectively. The prevalence was significantly higher in men than in women (OR = 2.6 and 2.3 for the low and high WC thresholds), as were all components of the MS except abdominal obesity measured by both thresholds. It also increased with age (OR values in age categories ranging from 2.7 to 28 when compared to the younger subjects for low WC and from 3.3 to 31 for the high WC cut-offs). The 10-year predicted risk of CHD by FRS did not depend on the threshold used. Globally, excellent agreement was observed between the three definitions of MS (kappa= 0.89), in particular between JIS and IDF (kappa = 0.93). Agreement was significantly higher in women than in men, and differed between age groups. CONCLUSION: Regardless of the definition used, the adult population of Luxembourg reveals a high MS prevalence. Our findings contribute to build evidence regarding the definitive construct of the MS, to help selecting the waist circumference thresholds for Europid populations, and to support the need to revise the guidelines for abdominal obesity levels.
Disciplines :
General & internal medicine
Author, co-author :
Alkerwi, Ala'a
Donneau, Anne-Françoise ; Université de Liège - ULiège > Département des sciences de la santé publique > Département des sciences de la santé publique
Sauvageot, Nicolas
Lair, Marie-Lise
Scheen, André ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Albert, Adelin ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique - Département de mathématique
Guillaume, Michèle ; Université de Liège - ULiège > Département des sciences de la santé publique > Informatique médicale et biostatistique - Santé publique : aspects spécifiques
Language :
English
Title :
Prevalence of the metabolic syndrome in Luxembourg according to the Joint Interim Statement definition estimated from the ORISCAV-LUX study.
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. ES Ford, Diabetes care 2005 28 7 1769 1778 10.2337/diacare.28.7.1769 15983333
Components of the "metabolic syndrome" and incidence of type 2 diabetes. RL Hanson G Imperatore PH Bennett WC Knowler, Diabetes 2002 51 10 3120 3127 10.2337/diabetes.51.10.3120 12351457
Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. DE Laaksonen HM Lakka LK Niskanen GA Kaplan JT Salonen TA Lakka, Am J Epidemiol 2002 156 11 1070 1077 10.1093/aje/kwf145 12446265
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. HM Lakka DE Laaksonen TA Lakka LK Niskanen E Kumpusalo J Tuomilehto JT Salonen, Jama 2002 288 21 2709 2716 10.1001/jama.288.21.2709 12460094
Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. M Pyorala H Miettinen P Halonen M Laakso K Pyorala, Arteriosclerosis, thrombosis, and vascular biology 2000 20 2 538 544 10669654
Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. HE Resnick K Jones G Ruotolo AK Jain J Henderson W Lu BV Howard, Diabetes care 2003 26 3 861 867 10.2337/diacare.26.3.861 12610050
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
The metabolic syndrome - a new worldwide definition. KG Alberti P Zimmet J Shaw, Lancet 2005 366 9491 1059 1062 10.1016/S0140-6736(05)67402-8 16182882
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. KG Alberti PZ Zimmet, Diabet Med 1998 15 7 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2- S 9686693
Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. B Balkau MA Charles T Drivsholm K Borch-Johnsen N Wareham JS Yudkin R Morris I Zavaroni R van Dam E Feskins, et al. Diabetes Metab 2002 28 364 376 12461473
The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. B Balkau M Vernay L Mhamdi M Novak D Arondel S Vol J Tichet E Eschwege, Diabetes Metab 2003 29 5 526 532 10.1016/S1262-3636(07)70067-8 14631330
Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr, et al. Cardiology in review 2005 13 6 322 327 16708441
Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). S Moebus JU Hanisch P Aidelsburger P Bramlage J Wasem KH Jockel, Cardiovasc Diabetol 2007 6 22 10.1186/1475-2840-6-22 17822558
[A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results]. P Zimmet MMA KG M Serrano Rios, Rev Esp Cardiol 2005 58 12 1371 1376 10.1016/S0300-8932(05)74065-3 16371194
The metabolic syndrome: a global public health problem and a new definition. P Zimmet D Magliano Y Matsuzawa G Alberti J Shaw, J Atheroscler Thromb 2005 12 6 295 300 16394610
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. KG Alberti RH Eckel SM Grundy PZ Zimmet JI Cleeman KA Donato JC Fruchart WP James CM Loria SC Smith Jr, Circulation 2009 120 16 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. JP Despres I Lemieux J Bergeron P Pibarot P Mathieu E Larose J Rodes-Cabau OF Bertrand P Poirier, Arteriosclerosis, thrombosis, and vascular biology 2008 28 6 1039 1049 10.1161/ATVBAHA.107.159228 18356555
The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. 2005 http://www.idf.org/idf-worldwide- definition-metabolic-syndrome
The metabolic syndrome: prevalence in worldwide populations. AJ Cameron JE Shaw PZ Zimmet, Endocrinology and metabolism clinics of North America 2004 33 2 351 375 table of contents 10.1016/j.ecl.2004.03.005 15158523
First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX). A Alkerwi N Sauvageot A-F Donneau M-L Lair S Couffignal J Beissel C Delagardelle Y Wagener A Albert M Guillaume, BMC Public Health 2010 10 468
Comparison of participants and non-participants to the ORISCAV-LUX population-based study on cardiovascular risk factors in Luxembourg. A Alkerwi N Sauvageot S Couffignal A Albert ML Lair M Guillaume, BMC Med Res Methodol 2010 10 80 10.1186/1471-2288-10-80 20819238
The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators. SS Anand S Yusuf V Vuksan S Devanesen P Montague L Kelemen J Bosch C Sigouin KK Teo E Lonn, et al. Can J Cardiol 1998 14 11 1349 1357 9854515
Validation of the Omron HEM-907 device for blood pressure measurement. MA El Assaad JA Topouchian BM Darne RG Asmar, Blood Press Monit 2002 7 4 237 241 10.1097/00126097-200208000-00006 12198340
Prediction of coronary heart disease using risk factor categories. PW Wilson RB D'Agostino D Levy AM Belanger H Silbershatz WB Kannel, Circulation 1998 97 18 1837 1847 9603539
The influence of age and body mass index on the metabolic syndrome and its components. CM Alexander PB Landsman SM Grundy, Diabetes Obes Metab 2008 10 3 246 250 10.1111/j.1463-1326.2006.00695.x 18269640
preventing and managing the global epidemic. Report of a WHO consultation. Obesity, World Health Organ Tech Rep Ser 2000 894 xii 1-253 11234459
Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. B Balkau MA Charles T Drivsholm K Borch-Johnsen N Wareham JS Yudkin R Morris I Zavaroni R van Dam E Feskins, et al. Diabetes Metab 2002 28 5 364 376 12461473
Waist circumference as a measure for indicating need for weight management. ME Lean TS Han CE Morrison, BMJ 1995 311 6998 158 161 7613427
The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. PT Katzmarzyk I Janssen R Ross TS Church SN Blair, Diabetes care 2006 29 2 404 409 10.2337/diacare.29.02. 06.dc05-1636 16443895
Ethnic-specific criteria for the metabolic syndrome: evidence from China. J Liu SM Grundy W Wang SC Smith GL Vega Z Wu Z Zeng W Wang D Zhao, Diabetes care 2006 29 6 1414 1416 10.2337/dc06-0481 16732037
Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. AC Santos H Barros, Diab Vasc Dis Res 2007 4 4 320 327 10.3132/dvdr.2007.059 18158702
Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. BM Cheung KL Ong YB Man LY Wong CP Lau KS Lam, J Clin Hypertens (Greenwich) 2006 8 8 562 570 10.1111/j.1524-6175.2006.05414.x 16896272
Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: the Diabetes in Germany (DIG) Study. C Koehler P Ott I Benke M Hanefeld, Horm Metab Res 2007 39 9 632 635 10.1055/s-2007-985816 17846969
Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study. AS Can TP Bersot, BMC Public Health 2007 7 353 10.1186/1471-2458-7-353 18088443
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. G Assmann R Guerra G Fox P Cullen H Schulte D Willett SM Grundy, The American journal of cardiology 2007 99 4 541 548 10.1016/j.amjcard.2006.08.045 17293200
Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. ES Ford, Diabetes care 2005 28 11 2745 2749 10.2337/diacare.28.11.2745 16249550